Central Florida — The U.S. Food and Drug Administration (FDA) issued a press release alerting consumers to avoid purchasing or using certain powdered infant formula products produced in Abbott Nutrition’s facility in Sturgis, Michigan. This is an ongoing investigation, and Abbott has initiated a voluntary recall of the potentially affected product. The FDA’s full press release can be found here.

The FDA is advising consumers not to use Similac, Alimentum, or EleCare powdered infant formulas if:

• The first two digits of the code are 22 through 37; and
• The code on the container contains K8, SH, or Z2; and
• The expiration date is 4-1-2022 (APR 2022) or later.

If your child is experiencing any Cronobacter infection symptoms or Salmonella symptoms, you should seek medical care for your child immediately.

Alternative Formula Use

Individuals should not use recalled infant formula and contact their health care provider for guidance on alternative infant formula use.

If you are a Florida Women, Infants, and Children (WIC) Program participant, do not use the recalled infant formula and do not discard or throw it out. Impacted Florida WIC Program participants should contact their local WIC office for information on how to return recalled infant formula for alternative replacements. The Florida Department of Health is also reaching out to Florida WIC Program participants.

WIC Contact Information

WIC Program participants should contact their County WIC program to return recalled infant formula for alternate replacements. See local WIC telephone numbers below:

Lake County WIC - 352-771-5559

Orange County WIC - 407-858-1494

Osceola County WIC - 407-343-2085

Seminole County WIC - 407-665-3705

Volusia County WIC - 1-866-942-3663

Additional Informational

Information regarding the FDA’s investigation of Cronobacter and Salmonella complaints in Abbott’s powdered infant formulas can be found here.

Information regarding Abbott’s voluntarily recall of powder formulas can be found on the FDA’s website here. Abbott also issued a press release, which can be found here.